NVAX
Novavax Inc
Price:  
5.39 
USD
Volume:  
14,582,709.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax WACC - Weighted Average Cost of Capital

The WACC of Novavax Inc (NVAX) is 8.1%.

The Cost of Equity of Novavax Inc (NVAX) is 10.25%.
The Cost of Debt of Novavax Inc (NVAX) is 5.50%.

Range Selected
Cost of equity 8.50% - 12.00% 10.25%
Tax rate 0.20% - 0.50% 0.35%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.4% - 9.7% 8.1%
WACC

Novavax WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.01 1.27
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.50% 12.00%
Tax rate 0.20% 0.50%
Debt/Equity ratio 0.86 0.86
Cost of debt 4.00% 7.00%
After-tax WACC 6.4% 9.7%
Selected WACC 8.1%